NET PROFIT (x1000 DKK)
EMPLOYEES
Arcedi Biotech ApS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-42,216
|
-33,236
|
-8,880 |
Total assets |
137,153
|
126,419
|
114,921 |
Current assets |
12,038
|
9,803
|
7,977 |
Current liabilities |
7,185
|
6,322
|
131,606 |
Equity capital |
-85,797
|
-53,326
|
-29,125 |
- share capital |
80
![]() |
80
![]() |
80 |
Employees (average) |
15
![]() |
15
![]() |
15 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
-62.6%
|
-42.2%
|
-25.3% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | |||
Current ratio |
167.5%
|
155.1%
|
6.1% |
Return on equity (ROE) |
49.2%
|
62.3%
|
30.5% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.